These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 32422969

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
    Blair IP, Williams KL, Warraich ST, Durnall JC, Thoeng AD, Manavis J, Blumbergs PC, Vucic S, Kiernan MC, Nicholson GA.
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
    [Abstract] [Full Text] [Related]

  • 23. RNA-binding proteins with prion-like domains in health and disease.
    Harrison AF, Shorter J.
    Biochem J; 2017 Apr 07; 474(8):1417-1438. PubMed ID: 28389532
    [Abstract] [Full Text] [Related]

  • 24. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.
    Keller BA, Volkening K, Droppelmann CA, Ang LC, Rademakers R, Strong MJ.
    Acta Neuropathol; 2012 Nov 07; 124(5):733-47. PubMed ID: 22941224
    [Abstract] [Full Text] [Related]

  • 25. Molecular basis of amyotrophic lateral sclerosis.
    Liscic RM, Breljak D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):370-2. PubMed ID: 20655970
    [Abstract] [Full Text] [Related]

  • 26. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH.
    Curr Opin Neurol; 2012 Dec 30; 25(6):701-7. PubMed ID: 23041957
    [Abstract] [Full Text] [Related]

  • 27. Using yeast models to probe the molecular basis of amyotrophic lateral sclerosis.
    Bastow EL, Gourlay CW, Tuite MF.
    Biochem Soc Trans; 2011 Oct 30; 39(5):1482-7. PubMed ID: 21936838
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology.
    Ince PG, Highley JR, Kirby J, Wharton SB, Takahashi H, Strong MJ, Shaw PJ.
    Acta Neuropathol; 2011 Dec 30; 122(6):657-71. PubMed ID: 22105541
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
    Alrafiah AR.
    In Vivo; 2018 Dec 30; 32(5):983-998. PubMed ID: 30150420
    [Abstract] [Full Text] [Related]

  • 33. RNA and Protein Interactors with TDP-43 in Human Spinal-Cord Lysates in Amyotrophic Lateral Sclerosis.
    Volkening K, Keller BA, Leystra-Lantz C, Strong MJ.
    J Proteome Res; 2018 Apr 06; 17(4):1712-1729. PubMed ID: 29513014
    [Abstract] [Full Text] [Related]

  • 34. Novel miR-b2122 regulates several ALS-related RNA-binding proteins.
    Hawley ZCE, Campos-Melo D, Strong MJ.
    Mol Brain; 2017 Oct 02; 10(1):46. PubMed ID: 28969660
    [Abstract] [Full Text] [Related]

  • 35. Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.
    Aizawa H, Hideyama T, Yamashita T, Kimura T, Suzuki N, Aoki M, Kwak S.
    J Clin Neurosci; 2016 Oct 02; 32():128-9. PubMed ID: 27343041
    [Abstract] [Full Text] [Related]

  • 36. Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS: implications for amyotrophic lateral sclerosis.
    Lu L, Zheng L, Si Y, Luo W, Dujardin G, Kwan T, Potochick NR, Thompson SR, Schneider DA, King PH.
    J Biol Chem; 2014 Nov 14; 289(46):31792-31804. PubMed ID: 25239623
    [Abstract] [Full Text] [Related]

  • 37. TDP-43 and FUS en route from the nucleus to the cytoplasm.
    Ederle H, Dormann D.
    FEBS Lett; 2017 Jun 14; 591(11):1489-1507. PubMed ID: 28380257
    [Abstract] [Full Text] [Related]

  • 38. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
    Strong MJ, Volkening K.
    FEBS J; 2011 Oct 14; 278(19):3569-77. PubMed ID: 21810174
    [Abstract] [Full Text] [Related]

  • 39. Mutation analysis of SOD1, C9orf72, TARDBP and FUS genes in ethnically-diverse Malaysian patients with amyotrophic lateral sclerosis (ALS).
    Edgar S, Ellis M, Abdul-Aziz NA, Goh KJ, Shahrizaila N, Kennerson ML, Ahmad-Annuar A.
    Neurobiol Aging; 2021 Dec 14; 108():200-206. PubMed ID: 34404558
    [Abstract] [Full Text] [Related]

  • 40. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development.
    Bowerman M, Murray LM, Scamps F, Schneider BL, Kothary R, Raoul C.
    Eur J Med Genet; 2018 Nov 14; 61(11):685-698. PubMed ID: 29313812
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.